European Archives - Page 860 of 982 - European Medical Journal

EMJ

Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer

Berlin, Germany, April 29, 2016 – Glycotope GmbH, a clinical-stage immuno-oncology company built on world-leading glyco-biology expertise, today…

EMJ

Neurological Expertise Crucial to Deal with Devastating Zika Consequences

London, 28 April 2016 — “The Zika virus is more and more showing its ugly face, and the international community increasingly realises the dimensions of…

EMJ Gastroenterology 5 [Suppl 6] 2016

The challenges of, and opportunities for optimal long-term management of Crohn’s disease (CD) and realworld experience of managing CD…

In It for the Long Haul: Managing the Complexity of Crohn’s Disease

CD is a complex disease, which requires effective treatment options to improve the quality of life for patients.

Management of Ulcerative Colitis: Putting Patients at the Centre

The treatment landscape of ulcerative colitis (UC) is changing, with new treatment options becoming available and insights into disease management…

EMJ

MedDay appoints Catherine Moukheibir as Chairman of its Board of Directors

Paris, France, 27 April 2016 – MedDay, a biotechnology company focused on the treatment of nervous system disorders, today announces the appointment of…

EMJ

Celyad Receives Certification for C-Cure® Non-Clinical Data from the European Medicines Agency (EMA)

C-Cure® (C3BS-CQR-1) is a cardiovascular lineage-committed cell therapy product being developed for the treatment of ischemic heart failure

EMJ

Introducing EMJ Urology 4.1

United Kingdom, April 21, 2016: This edition of the EMJ Urology eJournal, as in previous editions, is full of the latest news, reviews, interviews, and…

Prevention and Management of Biopsy Complications

Prostate biopsy is currently an essential procedure for prostate cancer diagnosis and the transrectal approach is most commonly used by European…

Review of the 31st Annual European Association of Urology Congress 2016

Being home to more than 200 biotechnology companies, and having once been voted the world’s most liveable city, Munich, Germany, was a perfect host for…